Elsevier’s 2026 Intravenous Medications - Elsevier E-Book on VitalSource, 42nd Edition
**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Medical/Surgical**
Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
ISBNコード :
9780443269615
出版日 :
23-06-2025
**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Medical/Surgical**
Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
特長
- Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference
- Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more
- Additional drug monographs are provided on the Evolve website
- Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks
- Blue-screened text calls attention to special circumstances not covered by Black Box Warnings
- Dosage and dilution charts within monographs provide quick summaries of essential clinical information
- Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients
- Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds
- Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks.
- NEW! Drug monographs for 8 newly approved drugs by the FDA include the most current information
- NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications
- NEW! Best practices guidelines for the preparation and administration of injectable drugs are provided from the National Coalition for IV Push Safety
著者情報
By Shelly Rainforth Collins, PharmD, BCGP, President, Drug Information Consultants, Chesapeake, Virginia, USA
| ISBN Number | 9780443269615 |
|---|---|
| Description Author List | By Shelly Rainforth Collins, PharmD, BCGP, President, Drug Information Consultants, Chesapeake, Virginia, USA |
| Copyright Year | 2026 |
| Edition Number | 42 |
| Format | E-Book |
| Trim | Other |
| Imprint | Elsevier |
| Page Count | 0 |
| Publication Date | 23 Jun 2025 |
| Stock Status | IN STOCK |
Evolve Website Information
General Dilution Charts
How to Use This Book
Preface
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
Preparation and Administration of Injectable Drugs
IV Drugs
Appendix
A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
B: FDA Pregnancy Categories
C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
D: Information for Patients Receiving Immunosuppressive Agents
E: Recently Approved Drugs
General Dilution Charts
How to Use This Book
Preface
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
Preparation and Administration of Injectable Drugs
IV Drugs
Appendix
A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
B: FDA Pregnancy Categories
C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
D: Information for Patients Receiving Immunosuppressive Agents
E: Recently Approved Drugs
あなたのレビューを投稿する
